Chicago Equity Partners LLC lowered its holdings in Cutera, Inc. (NASDAQ:CUTR) by 11.0% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,905 shares of the medical device company’s stock after selling 1,230 shares during the period. Chicago Equity Partners LLC’s holdings in Cutera were worth $498,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of CUTR. State of Alaska Department of Revenue bought a new position in Cutera in the fourth quarter worth about $125,000. Ladenburg Thalmann Financial Services Inc. lifted its holdings in Cutera by 3,400.0% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,500 shares of the medical device company’s stock worth $159,000 after acquiring an additional 3,400 shares during the last quarter. Alambic Investment Management L.P. bought a new position in Cutera in the fourth quarter worth about $204,000. Teacher Retirement System of Texas bought a new position in Cutera in the fourth quarter worth about $206,000. Finally, Rehmann Capital Advisory Group bought a new position in Cutera in the fourth quarter worth about $222,000. 96.26% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities analysts have issued reports on the stock. TheStreet cut shares of Cutera from a “b-” rating to a “c+” rating in a report on Tuesday, May 15th. ValuEngine cut shares of Cutera from a “strong-buy” rating to a “buy” rating in a report on Wednesday, May 9th. BidaskClub raised shares of Cutera from a “buy” rating to a “strong-buy” rating in a report on Tuesday, May 8th. Zacks Investment Research cut shares of Cutera from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 18th. Finally, Stifel Nicolaus assumed coverage on shares of Cutera in a report on Monday, April 16th. They issued a “hold” rating and a $55.00 target price on the stock. Three investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Cutera presently has a consensus rating of “Buy” and an average price target of $46.67.
CUTR opened at $41.15 on Monday. The company has a market cap of $561.04 million, a PE ratio of 53.44, a price-to-earnings-growth ratio of 1.72 and a beta of 0.48. Cutera, Inc. has a twelve month low of $20.05 and a twelve month high of $56.05.
Cutera (NASDAQ:CUTR) last released its quarterly earnings results on Tuesday, May 8th. The medical device company reported ($0.02) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.01 by ($0.03). The business had revenue of $34.10 million for the quarter, compared to the consensus estimate of $35.27 million. Cutera had a net margin of 18.54% and a return on equity of 16.12%. The business’s quarterly revenue was up 16.4% on a year-over-year basis. During the same period last year, the firm posted ($0.07) EPS. sell-side analysts forecast that Cutera, Inc. will post 0.57 EPS for the current year.
In other Cutera news, insider James A. Reinstein purchased 2,800 shares of the business’s stock in a transaction dated Friday, May 11th. The shares were bought at an average price of $35.55 per share, with a total value of $99,540.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gregory A. Barrett purchased 5,450 shares of the business’s stock in a transaction dated Friday, May 11th. The shares were acquired at an average cost of $36.98 per share, for a total transaction of $201,541.00. The disclosure for this purchase can be found here. Insiders own 11.60% of the company’s stock.
Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.
Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTR).
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.